methyl (2S)-2-[(tert-butoxycarbonyl)amino]-3-[4-(2-tert-butyl-1,1-dioxido-3-oxo-2,3-dihydroisothiazol-5-yl)-3-chlorophenyl]propanoate | 850317-92-9

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: methyl (2S)-2-[(tert-butoxycarbonyl)amino]-3-[4-(2-tert-butyl-1,1-dioxido-3-oxo-2,3-dihydroisothiazol-5-yl)-3-chlorophenyl]propanoate
• 英文别名: methyl (2S)-3-[4-(2-tert-butyl-1,1,3-trioxo-1,2-thiazol-5-yl)-3-chlorophenyl]-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate
• CAS: 850317-92-9
• 化学式: C₂₂H₂₉ClN₂O₇S
• 分子量: 501.0
• InChiKey: ZWVBBUBBEJJSQH-INIZCTEOSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  33
• 可旋转键数：
  9
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  128
• 氢给体数：
  1
• 氢受体数：
  7

反应信息

• 作为反应物：
  描述：

  methyl (2S)-2-[(tert-butoxycarbonyl)amino]-3-[4-(2-tert-butyl-1,1-dioxido-3-oxo-2,3-dihydroisothiazol-5-yl)-3-chlorophenyl]propanoate 在 锂硼氢 、 三乙胺 、 三氟乙酸 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 4.58h， 生成 (2S)-2-(tert-butoxycarbonyl)amino-3-{3-chloro-4-[(5S)-1,1-dioxido-3-oxoisothiazolidin-5-yl]phenyl}propanoic acid
  参考文献：
  名称：

  Potent Benzimidazole Sulfonamide Protein Tyrosine Phosphatase 1B Inhibitors Containing the Heterocyclic (S)-Isothiazolidinone Phosphotyrosine Mimetic

  摘要：

  Potent nonpeptidic benzimidazole sulfonamide inhibitors of protein tyrosine phosphatase 1B (PTP1B) were derived from the optimization of a tripeptide containing the novel (S)-isothiazolidinone ((S)-IZD) phosphotyrosine ( pTyr) mimetic. An X-ray cocrystal structure of inhibitor 46/PTP1B at 1.8 angstrom resolution demonstrated that the benzimidazole sulfonamides form a bidentate H bond to Asp48 as designed, although the aryl group of the sulfonamide unexpectedly interacts intramolecularly in a pi-stacking manner with the benzimidazole. The ortho substitution to the (S)-IZD on the aryl ring afforded low nanomolar enzyme inhibitors of PTP1B that also displayed low caco-2 permeability and cellular activity in an insulin receptor (IR) phosphorylation assay and an Akt phosphorylation assay. The design, synthesis, and SAR of this novel series of benzimidazole sulfonamide containing (S)-IZD inhibitors of PTP1B are presented herein.

  DOI：

  10.1021/jm0600904
• 作为产物：
  描述：

  (2S)-3-(4-氨基苯基)-2-[(叔丁氧基羰基)氨基]丙酸甲酯 在 盐酸 、 N-氯代丁二酰亚胺 、 四丁基氯化铵 、 palladium diacetate 、 三乙胺 、 sodium nitrite 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 27.17h， 生成 methyl (2S)-2-[(tert-butoxycarbonyl)amino]-3-[4-(2-tert-butyl-1,1-dioxido-3-oxo-2,3-dihydroisothiazol-5-yl)-3-chlorophenyl]propanoate
  参考文献：
  名称：

  Potent Benzimidazole Sulfonamide Protein Tyrosine Phosphatase 1B Inhibitors Containing the Heterocyclic (S)-Isothiazolidinone Phosphotyrosine Mimetic

  摘要：

  Potent nonpeptidic benzimidazole sulfonamide inhibitors of protein tyrosine phosphatase 1B (PTP1B) were derived from the optimization of a tripeptide containing the novel (S)-isothiazolidinone ((S)-IZD) phosphotyrosine ( pTyr) mimetic. An X-ray cocrystal structure of inhibitor 46/PTP1B at 1.8 angstrom resolution demonstrated that the benzimidazole sulfonamides form a bidentate H bond to Asp48 as designed, although the aryl group of the sulfonamide unexpectedly interacts intramolecularly in a pi-stacking manner with the benzimidazole. The ortho substitution to the (S)-IZD on the aryl ring afforded low nanomolar enzyme inhibitors of PTP1B that also displayed low caco-2 permeability and cellular activity in an insulin receptor (IR) phosphorylation assay and an Akt phosphorylation assay. The design, synthesis, and SAR of this novel series of benzimidazole sulfonamide containing (S)-IZD inhibitors of PTP1B are presented herein.

  DOI：

  10.1021/jm0600904

文献信息

• Inhibitors of proteins that bind phosphorylated molecules
  申请人：Combs P. Andrew

  公开号：US20050272778A1

  公开（公告）日：2005-12-08

  The present invention provides compounds that can modulate the activity of a target protein, such as a phosphatase, that selectively binds phosphorylated peptides or proteins. The present compounds can be useful in treating diseases or disorders, including, for example, diabetes and obesity, that are connected directly or indirectly to the activity of the target protein.

  本发明提供了可以调节目标蛋白活性的化合物，例如选择性结合磷酸化肽或蛋白质的磷酸酶。这些化合物可以用于治疗与目标蛋白活性直接或间接相关的疾病或障碍，例如糖尿病和肥胖症。